Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony D Ho

Showing results (201-210 of 346) with videos related to

Pageof 35
Sort By:
British Journal of Haematology|November 30, 2004
High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II studyJolanta B Perz, Stefan O Schonland, Michael Hundemer, et al.
Journal of Clinical Apheresis|April 29, 2014
Rescue stem cell mobilization with plerixafor economizes leukapheresis in patients with multiple myelomaMichael Hundemer, Melanie Engelhardt, Thomas Bruckner, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2019
Patients With Malignant Lymphoma and HIV Infection Experiencing Remission After First-Line Treatment Have an Excellent PrognosisKatharina Kriegsmann, Julia S Klee, Manfred Hensel, et al.
Haematologica|January 8, 2010
Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditionsKatharina Schallmoser, Christina Bartmann, Eva Rohde, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 28, 2014
Mesenchymal stem cells are sensitive to treatment with kinase inhibitors and ionizing radiationNils H Nicolay, Eva Sommer, Ramon Lopez Perez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2013
Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor loadKai Neben, Anna Jauch, Thomas Hielscher, et al.
Cancer|April 12, 2013
Autologous retransplantation for patients with recurrent multiple myeloma: a single-center experience with 200 patientsLeopold Sellner, Christiane Heiss, Axel Benner, et al.
Science Translational Medicine|May 28, 2010
Proteins required for centrosome clustering in cancer cellsBlanka Leber, Bettina Maier, Florian Fuchs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 17, 2011
Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myelomaBrigitte Neuber, Isabelle Herth, Claudia Tolliver, et al.
Blood|August 14, 2014
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosisGiovanni Palladini, Ute Hegenbart, Paolo Milani, et al.
Pageof 35

Showing results (201-210 of 346) with videos related to

Sort By:
Pageof 35
British Journal of Haematology|November 30, 2004
High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II studyJolanta B Perz, Stefan O Schonland, Michael Hundemer, et al.
Journal of Clinical Apheresis|April 29, 2014
Rescue stem cell mobilization with plerixafor economizes leukapheresis in patients with multiple myelomaMichael Hundemer, Melanie Engelhardt, Thomas Bruckner, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2019
Patients With Malignant Lymphoma and HIV Infection Experiencing Remission After First-Line Treatment Have an Excellent PrognosisKatharina Kriegsmann, Julia S Klee, Manfred Hensel, et al.
Haematologica|January 8, 2010
Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditionsKatharina Schallmoser, Christina Bartmann, Eva Rohde, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 28, 2014
Mesenchymal stem cells are sensitive to treatment with kinase inhibitors and ionizing radiationNils H Nicolay, Eva Sommer, Ramon Lopez Perez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2013
Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor loadKai Neben, Anna Jauch, Thomas Hielscher, et al.
Cancer|April 12, 2013
Autologous retransplantation for patients with recurrent multiple myeloma: a single-center experience with 200 patientsLeopold Sellner, Christiane Heiss, Axel Benner, et al.
Science Translational Medicine|May 28, 2010
Proteins required for centrosome clustering in cancer cellsBlanka Leber, Bettina Maier, Florian Fuchs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 17, 2011
Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myelomaBrigitte Neuber, Isabelle Herth, Claudia Tolliver, et al.
Blood|August 14, 2014
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosisGiovanni Palladini, Ute Hegenbart, Paolo Milani, et al.
Pageof 35